C-RBFEEffePharm Ltd.
NAD+ precursors, liposomal delivery, bioactive ingredients
consumer products
Loading
Loading section...0-100 chain-logic scale · 15 dimensions · scored on public evidence
←All companiesC-RBFE
C-RBFEC-RBFENAD+ precursors, liposomal delivery, bioactive ingredients
0-100 chain-logic scale · 15 dimensions · scored on public evidence
This study is to assess the safety and tolerability of NMNH as a dietary supplement for human consumption. The current study aims to comprehensively evaluate its potential effects on pharmacokinetics, physical performance, biological age and overall quality of life. These findings will expand our understanding of NMNH therapeutic potential and guide its future clinical applications in anti-aging interventions.
This will be a multi-center, two arm study in 66 healthy adults. Subjects will complete a screening visit (V1, Day -7) to determine eligibility for the study based on Inclusion \& Exclusion Criteria, patient history and safety measures. Eligibility confirmation will be done on visit 2 (Day 1). Patients successfully completing screen will be assigned to either of the two treatments. Subjects will receive the treatment for at-home use and will also be given diaries for recording information of medication, and adverse events. At 2 different intervals i.e. Day 30 and Day 60 (V3, V4) subjects will return to the clinic to review and collect patient diaries, safety data and medication reconciliation. Efficacy and safety assessments will be done at baseline, Day 30 and Day 60 .
Effepharm Won the 2020 “NEW POWER” Innovation Award For the NMN Brand Material UTHEVER® - EffePharm Home Our Products Heathy-Aging Human Nutrition Personal Care Liposomal Products Effe-PLUS Platform LipoAvail® Liposomal Technology CelleSperse® Micelles Technology EncapCirc® Microencapsulation Technology Where to Buy --> About Us Who We Are Why EffePharm Advisory Board 100% Traceable Sustainability Our Service White Papers Latest Updates News Blog --> EN CN RU ES PT 中 --> Contact Us Home Our Products Heathy-Aging Human Nutrition Personal Care Liposomal Products Effe-PLUS Platform LipoAvail® Lip … ntact Us Home Latest Updates News Effepharm Won the 2020 “NEW POWER” Innovation Award For the NMN Brand Material UTHEVER® 2020-10-27 | EffePharm Asiaceutical Summit & Expo 2020 took place in Guangzhou from October 21 st to 23 rd . This conference was hosted by the Herbridge, which gathered the experts in foods, beverage and health care industry. Experts provided cutting edge perspectives under the circumstances of coronavirus, 5G technology commercialization, and new form … pment, and find the capital investment for future unicorn companies. During the prize-award ceremony, Effepharm stood out and won the “New Power” Innovation Award voting by new health product raw material evaluation experts, R&D department, and capital side. Chief regulatory officer of Effepharm, Hank Huang, delivered a speech on UTHEVER®NMN “Longevity medicine” at the expo. Staying young and keeping energetic have always been the top hottest topics among scientific and h … terprises and pharmaceutical research institutes for a long time to develop and apply NMN in the pharmaceutical field, such as cancer adjuvant drugs and other disease treatment projects. At the same time, Effepharm, so far, has and would continue to fund the research on the anti-aging of human health at Fudan University, Sichuan University, and Tianjin Medical University, providing multi-dimensional innovative ideas for human health development. Prev: NMN studies revealed tha
Консультативный совет - EffePharm Главная Наши Продукты Здоровое старение Человеческое питание Личная гигиена Липосомальные продукты Платформа Effe-PLUS Липосомальная технология LipoAvail® Мицеллярная технология CelleSperse® Технология микрокапсулирования EncapCirc® Where to Buy --> О Нас О нас Почему ЭффеФарм Консультативный совет 100% отслеживаемость Стабильность Наш сервис Технические документы Последние обновления Новости Блог --> EN CN RU ES PT 中 --> Свяжитесь с нами Главная Наши Продукты Здоровое старение Человеческое питание Личная гигиена Липосомальные продукты Платформа Effe-PLUS Липо … Александра фон Гумбольдта в 2006 году и премию журнала Thieme Chemistry Journal Award в 2011 году. Доктор Тонг опубликовал десятки статей в ведущих международных журналах, таких как J. Am. Chem Soc，Angew. Chem. Int. Ed. Org. Lett.、Chem. Commun. Запишитесь на прием к экспертам EffePharm Вместе мы строим более здоровое будущее. Свяжитесь с нами Подписывайтесь на Нас Наши Продукты Здоровое старение Человеческое питание Личная гигиена Липосомальные продукты Платформа Effe-PLUS Ли
Consejo Asesor - EffePharm Inicio Nuestros Productos Envejecimiento saludable Nutrición Humana Cuidado Personal Productos liposomales Plataforma Effe-PLUS Tecnología liposomal LipoAvail® Tecnología de micelas CelleSperse® Tecnología de microencapsulación EncapCirc® Where to Buy --> Sobre Nosotros ¿Quiénes somos? ¿Por qué EffePharm? Consejo asesor 100% rastreable Sostenibilidad Nuestro Servicio Documentación Técnica Las últimas novedades Noticias Blog --> EN CN RU ES PT 中 --> Contáctenos Inicio Nuestros Productos Envejecimiento saludable Nutrición Humana Cuidado Personal Productos liposomales P
NAD+ Market Game-Changer: EffePharm Leads "Clinical & Compliance" Charge at SupplySide Global 2025 - EffePharm Home Our Products Heathy-Aging Human Nutrition Personal Care Liposomal Products Effe-PLUS Platform LipoAvail® Liposomal Technology CelleSperse® Micelles Technology EncapCirc® Microencapsulation Technology Where to Buy --> About Us Who We Are Why EffePharm Advisory Board 100% Traceable Sustainability Our Service White Papers Latest Updates News Blog --> EN CN RU ES PT 中 --> Contact Us Home Our Products Heathy-Aging Human Nutrition Personal Care Liposomal Products Effe-PLU … a New Dietary Ingredient (NDI) notification for UTHEVER ® NMN. Furthermore, our application for EFSA novel food certification is progressing. This ongoing work reflects our commitment to building a fully compliant pathway for our partners. By choosing UTHEVER ® , you align with a partner actively investing in the regulatory process. Our aim is to help de-risk your development timeline and provide the substantiated documentation needed to pursue market access in North America … olve a universal problem: most supplements are poorly absorbed. Now, brands can apply that same breakthrough tech to any ingredient that struggles with delivery. Case in point: Liposomal Glutathione: 13x higher bioavailability than conventional forms. Liposomal Vitamin C: 7.86x better absorption for immune and collagen support. Liposomal Curcumin: 107.5x improved uptake (game over for inflammation and liver health). Liposomal Berberine: 33.3x higher absorption (metabolic heal
Conselho Consultivo - EffePharm Início Nossos Produtos Envelhecimento Saudável Nutrição Humana Higiene pessoal Produtos lipossomais Plataforma Effe-PLUS Tecnologia Lipossomal LipoAvail® Tecnologia de Micelas CelleSperse® Tecnologia de microencapsulação EncapCirc® Where to Buy --> Sobre Sobre Nós Por que EffePharm Conselho Consultivo 100% rastreável Sustentabilidade o Serviço White Papers Ultimas atualizações Notícias Blog --> EN CN RU ES PT 中 --> Entre em contato Início Nossos Produtos Envelhecimento Saudável Nutrição Humana Higiene pessoal Produtos lipossomais Plataforma Effe-PLUS Tecnologia
科学委员会 - 音芙医药 首页 产品 健康抗老 人类营养 个人护理 LipoAvail™脂质体产品 Effe-PLUS增效平台 LipoAvail™脂质体技术 CelleSperse™微胶束技术 EncapCirc®微囊化技术 Where to Buy --> 关于音芙 品牌故事 我们的优势 科学委员会 100%可追溯 可持续发展 我们的服务 白皮书 新闻动态 新闻 博客 EN 联系我们 首页 产品 健康抗老 人类营养 个人护理 LipoAvail™脂质体产品 Effe-PLUS增效平台 LipoAvail™脂质体技术 CelleSperse™微胶束技术 EncapCirc®微囊化技术 Where to Buy --> 关于音芙 品牌故事 我们的优势 科学委员会 100%可追溯 可持续发展 我们的服务 白皮书 新闻动态 新闻 博客 联系我们 首页 关于音芙 科学委员会 科学委员会 科学顾问 Dr. Richard Kaszynski Richard H. Kaszynski, MD, Ph.D. 斯坦福SOLUTION联合创始人兼董事 ASHINAGA 组织理事 Richard Kaszynski 博士曾任哈佛大学医学院研究员，在东京从事急诊医学工作，并为刚果民主共和国的埃博拉战略提供建议。他还是斯坦福解决方案项目的创始人，致力于在全球推广公平的医疗创新。 科学顾问 方显杰博士 上 … 。 德国罗斯托克大学Leibniz催化研究所博士后研究员。 获奖：2006年获得德国洪堡学者奖（Alexander von Humboldt Research Fellowship），2011年获得Thieme Chemistry Journal Award。 在J. Am. Chem Soc，Angew. Chem. Int. Ed. Org. Lett.，Chem. Commun等国际杂志发表数十篇论文。 联系我们，了解更多信息 引领每个人迈向更加精彩、健康的未来。 联系我们 产品 健康抗老 人类营养 个人护理 LipoAvail™脂质体产品 Effe-PLUS增效平台 LipoAvail™脂质体技术 CelleSperse™微胶束技术 EncapCirc®微囊化技术 Where to Buy --> 关于音芙 品牌故事 我们的优势 科学委员会 100%可追溯 可持续发展 我们的服务 白皮书 新闻动态 新闻 博客 联系我们 版权所有 © 2026 EffePharm . All Rights Reserved. 沪ICP备2024107411
News - Page 3 of 5 - EffePharm Home Our Products Heathy-Aging Human Nutrition Personal Care Liposomal Products Effe-PLUS Platform LipoAvail® Liposomal Technology CelleSperse® Micelles Technology EncapCirc® Microencapsulation Technology Where to Buy --> About Us Who We Are Why EffePharm Advisory Board 100% Traceable Sustainability Our Service White Papers Latest Updates News Blog --> EN CN RU ES PT 中 --> Contact Us Home Our Products Heathy-Aging Human Nutrition Personal Care Liposomal Products Effe-PLUS Platform LipoAvail® Liposomal Technology CelleSperse® Micelles Technology EncapCirc® Microen … er® NMN 2020-12-04 Effepharm’s R&D Director got an outstanding achievement award for scientific research Effepharm’s R&D Director got an outstanding achievement award for scientific research Dr. Jianjun Yu, Effepharm’s R&D Director, got an outstanding achievement award for scientific research of the ministry of education in October 2019. The winning project was “Rare earth micellar catalysis technology of green fine organic synthesis”. Through many years’
EffePharm Welcomes Dr. Richard Kaszynski to Advisory Board - EffePharm Home Our Products Heathy-Aging Human Nutrition Personal Care Liposomal Products Effe-PLUS Platform LipoAvail® Liposomal Technology CelleSperse® Micelles Technology EncapCirc® Microencapsulation Technology Where to Buy --> About Us Who We Are Why EffePharm Advisory Board 100% Traceable Sustainability Our Service White Papers Latest Updates News Blog --> EN CN RU ES PT 中 --> Contact Us Home Our Products Heathy-Aging Human Nutrition Personal Care Liposomal Products Effe-PLUS Platform LipoAvail® Liposomal Technology CelleSperse
Advisory Board - EffePharm Home Our Products Heathy-Aging Human Nutrition Personal Care Liposomal Products Effe-PLUS Platform LipoAvail® Liposomal Technology CelleSperse® Micelles Technology EncapCirc® Microencapsulation Technology Where to Buy --> About Us Who We Are Why EffePharm Advisory Board 100% Traceable Sustainability Our Service White Papers Latest Updates News Blog --> EN CN RU ES PT 中 --> Contact Us Home Our Products Heathy-Aging Human Nutrition Personal Care Liposomal Products Effe-PLUS Platform LipoAvail® Liposomal Technology CelleSperse® Micelles Technology EncapCirc® Microencaps … e Germany as a postdoctor in 2005. Dr. Tong got Alexander von Humboldt Research Fellowship in 2006, and Thieme Chemistry Journal Award in 2011. Dr. Tong published dozens of articles in top international magazines like J. Am. Chem Soc，Angew. Chem. Int. Ed. Org. Lett.、Chem. Commun. Schedule an Appointment with EffePharm's Experts Together, we build a healthier future. Contact us Follow Us Our Products Heathy-Aging Human Nutrition Personal Care Liposomal Products Effe-PLUS Platf
EffePharm - Buy Bulk NMN&NMNH powder and LipoAvail liposomal technology provider. Home Our Products Heathy-Aging Human Nutrition Personal Care Liposomal Products Effe-PLUS Platform LipoAvail® Liposomal Technology CelleSperse® Micelles Technology EncapCirc® Microencapsulation Technology Where to Buy --> About Us Who We Are Why EffePharm Advisory Board 100% Traceable Sustainability Our Service White Papers Latest Updates News Blog --> EN CN RU ES PT 中 --> Contact Us Home Our Products Heathy-Aging Human Nutrition Personal Care Liposomal Products Effe-PLUS Platform LipoAvail® Liposomal Technol
UTHEVER® NMN Supplier - EffePharm Home Our Products Heathy-Aging Human Nutrition Personal Care Liposomal Products Effe-PLUS Platform LipoAvail® Liposomal Technology CelleSperse® Micelles Technology EncapCirc® Microencapsulation Technology Where to Buy --> About Us Who We Are Why EffePharm Advisory Board 100% Traceable Sustainability Our Service White Papers Latest Updates News Blog --> EN CN RU ES PT 中 --> Contact Us Home Our Products Heathy-Aging Human Nutrition Personal Care Liposomal Products Effe-PLUS Platform LipoAvail® Liposomal Technology CelleSperse® Micelles Technology EncapCirc® Micr … the European Union. However, EffePharm’s UTHEVER® NMN is leading the regulatory application process. As of February 2025, it has successfully passed the public consultation stage and is now undergoing EFSA’s scientific risk assessment. Approval of UTHEVER® would mark a significant milestone in the EU, potentially opening broader access to compliant, high-purity NMN bulk supplier products and wholesale channels across Europe. 03 Are there any side effects of NMN? NMN supplemen … product line of your brand; collaborating with a reliable NMN manufacturer will grant you not only scalability but also trustworthiness. Choose EffePharm – Your Trusted Source for the Best NMN Powder In today’s highly competitive supplement industry, one of the smartest moves is to build a partnership with a scientifically proven manufacturer of NMN like EffePharm. With its thoroughly tested, pharmaceutical-grade products and global reputation for excellence, EffePharm leads